Context Therapeutics Inc. (CNTX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-26

Context Therapeutics Inc. (CNTX) has filed 6 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-26. 4 Form 8-K material event filings were reported by CNTX in the last 90 days. InsiderAlpha tracks every CNTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Context Therapeutics Inc. (CNTX)

SEC CIK	0001842952

90-Day SEC Filing Activity

Form 4 filings (90d)	6
Form 8-K filings (90d)	4
Latest Form 4 filing	2026-06-26

Most-Active CNTX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Smith Karen L.	1	—
Stacey Jennifer Evans	1	—
Walker Luke Nathaniel	1	—
Pasternak Andy	1	—
Kantoff Philip W.	1	—

Recent CNTX Form 8-K Material Events

2026-06-26 — Item 5.03, 5.07, 9.01 [SEC]
2026-06-15 — Item 7.01, 8.01, 9.01 [SEC]
2026-05-18 — Item 1.01, 7.01, 9.01 [SEC]
2026-05-01 — Item 8.01 [SEC]
2026-04-02 — Item 7.01, 8.01, 9.01 · Clinical · positive [SEC]
Context Therapeutics announced that the FDA has granted Fast Track designation to CTIM-76, a Claudin 6 x CD3 T cell engaging bispecific antibody, for treating platinum-resistant ovarian cancer in patients who have exhausted standard therapies. Fast Track designation accelerates t

Recent Insider Filings

2026-06-26 — Pasternak Andy (Director)
2026-06-26 — Stacey Jennifer Evans (Director)
2026-06-26 — West Linda (Director)
2026-06-26 — Smith Karen L. (Director)
2026-06-26 — Walker Luke Nathaniel (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CNTX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CNTX Insider Trading — FAQ

What is the latest insider trade for CNTX?: Context Therapeutics Inc. (CNTX) had 6 insider filings in the last 90 days, with the most recent on 2026-06-26. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CNTX stock?: 0 insider purchases of CNTX were filed in the last 90 days.
How many insiders are selling CNTX stock?: 0 insider sales of CNTX were filed in the last 90 days.
Where can I see CNTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CNTX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live CNTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.